Mark Schroeder

17PUBLICATIONS
75CO-AUTHORS
AutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 18, 2026
Pulmonary Light Chain Deposition Disease in a Patient With Chronic Lymphocytic Leukemia.

|Apr 14, 2026
Safety and efficacy of ciltacabtagene autoleucel for relapsed/refractory multiple myeloma: a CIBMTR study.

Doris K Hansen, Danai Dima, Hira Mian

|Mar 19, 2025
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.

Zachariah DeFilipp, Haesook T Kim, Laura W Knight

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Nov 01, 2024
LINC01432 binds to CELF2 in newly diagnosed multiple myeloma promoting short progression-free survival to standard therapy.

Richa Mishra, Prasanth Thunuguntla, Alani Perkin

|May 29, 2023
Acute Graft-versus-Host Disease: An Update on New Treatment Options.

Dilan A Patel, Mallory Crain, Iskra Pusic

Pageof 3

Frequent Collaborators

3 joint publications

Taiga Nishihori

3 joint publications

Keith Stockerl-Goldstein

3 joint publications

Hira Mian

3 joint publications

Rahul Banerjee